Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

A family with dynamin 2-related centronuclear myopathy without ocular involvement

  • Park, Jin-Sung (Department of Neurology, Kyungpook National University Hosipital, Kyungpook National University School of Medicine) ;
  • Kim, Dae-Seong (Department of Neurology, Pusan National University Yangsan Hospital,) ;
  • Shin, Jin-Hong (Department of Neurology, Pusan National University Yangsan Hospital,)
  • Received : 2015.12.05
  • Accepted : 2016.01.26
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Centronuclear myopathy (CNM) is a rare congenital myopathy that is pathologically characterized by the centrally located nuclei in most of the muscle fibers. On clinical examination, dynamin 2 (DNM2)-related CNM typically shows distal dominant muscle atrophy, ptosis, ophthalmoplegia, and contracture. The reported cases of CNM in Caucasian studies show a high prevalence rate of early-onset ptosis and ophthalmoplegia and correlated with the severity of the disease. However, Asian reports show a low prevalence and late-onset ocular symptoms in DNM2-related CNM patients. p.R465W is one of the most commonly found mutations in Western countries, and all the cases showed ocular symptoms. The proband and his daughter had no ocular symptoms despite harboring the same p.R465W mutation. This family makes us speculate that ocular symptoms in DNM2-related CNM are influenced by ethnic background. In addition, this is the first familial case of DNM2-related CNM in Korea.

Keywords

References

  1. Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008;3:26. https://doi.org/10.1186/1750-1172-3-26
  2. Jungbluth H, Gautel M. Pathogenic mechanisms in centronuclear myopathies. Front Aging Neurosci 2014;6:339.
  3. Echaniz-Laguna A, Nicot AS, Carre S, Franques J, Tranchant C, Dondaine N, et al. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Neuromuscul Disord 2007;17:955-9. https://doi.org/10.1016/j.nmd.2007.06.467
  4. Bohm J, Biancalana V, Dechene ET, Bitoun M, Pierson CR, Schaefer E, et al. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat 2012;33:949-59. https://doi.org/10.1002/humu.22067
  5. Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 2005;37:1207-9. https://doi.org/10.1038/ng1657
  6. Catteruccia M, Fattori F, Codemo V, Ruggiero L, Maggi L, Tasca G, et al. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord 2013;23:229-38. https://doi.org/10.1016/j.nmd.2012.12.009
  7. Susman RD, Quijano-Roy S, Yang N, Webster R, Clarke NF, Dowling J, et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord 2010;20:229-37. https://doi.org/10.1016/j.nmd.2010.02.016
  8. Hanisch F, Muller T, Dietz A, Bitoun M, Kress W, Weis J, et al. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations. J Neurol 2011;258:1085-90. https://doi.org/10.1007/s00415-010-5889-5
  9. Chen T, Pu C, Wang Q, Liu J, Mao Y, Shi Q. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China. Neurol Sci 2015;36:735-41. https://doi.org/10.1007/s10072-014-2028-6
  10. Mori-Yoshimura M, Okuma A, Oya Y, Fujimura-Kiyono C, Nakajima H, Matsuura K, et al. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Clin Neurol Neurosurg 2012;114:678-83. https://doi.org/10.1016/j.clineuro.2011.10.040
  11. Park YE, Choi YC, Bae JS, Lee CH, Kim HS, Shin JH, et al. Clinical and pathological features of Korean patients with DNM2-related centronuclear myopathy. J Clin Neurol 2014;10:24-31. https://doi.org/10.3988/jcn.2014.10.1.24
  12. Fischer D, Herasse M, Bitoun M, Barragan-Campos HM, Chiras J, Laforet P, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 2006;129:1463-9. https://doi.org/10.1093/brain/awl071